Rafael Torgovicky
Founder chez Medexplore Ventures
Profil
Rafael Torgovicky is the founder of Medexplore Ventures (founded in 2018) and Gromit Therapeutics (founded in 2021).
He is currently working as an Advisor at Mount Sinai Innovation Partners since 2018.
Previously, he worked as a Vice President at Eli Lilly & Co. from 2015 to 2018, a Manager at Merck & Co., Inc. from 2008 to 2010, and an Advisor at Novartis AG from 2007 to 2008.
He also served as an Advisor at Israel Biotech Fund from 2016 to 2019 and as a General Partner at A.M.
Accelmed Management (2009) Ltd.
from 2019 to 2021.
Additionally, he is a member of the Board of Advisors at Vuja De Sciences, Inc. Dr. Torgovicky obtained his doctorate degree from Tel-Aviv University in 2002.
Postes actifs de Rafael Torgovicky
| Sociétés | Poste | Début |
|---|---|---|
Mount Sinai Innovation Partners
 Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Mount Sinai Innovation Partners is a private company that focuses on translating discoveries and inventions into healthcare products and services that benefit patients and society. The company is based in New York, NY. The company is responsible for evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. | Consultant / Advisor | 01/01/2018 |
| Medexplore Ventures | Founder | 01/01/2018 |
Anciens postes connus de Rafael Torgovicky
| Sociétés | Poste | Fin |
|---|---|---|
A.M. Accelmed Management (2009) Ltd.
 A.M. Accelmed Management (2009) Ltd. Investment ManagersFinance A.M. Accelmed Management (2009) Ltd (Accelmed) is a private equity subsidiary of Arkin Moshe founded in 2009. The firm is headquartered in Miami, Florida. | Private Equity Investor | 31/12/2021 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Consultant / Advisor | 02/01/2019 |
| ELI LILLY AND COMPANY | Private Equity Investor | 02/01/2018 |
| MERCK & CO., INC. | Corporate Officer/Principal | 30/12/2010 |
| NOVARTIS AG | Consultant / Advisor | 30/03/2008 |
Formation de Rafael Torgovicky
| Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Entreprise privées | 6 |
|---|---|
A.M. Accelmed Management (2009) Ltd.
A.M. Accelmed Management (2009) Ltd. Investment ManagersFinance A.M. Accelmed Management (2009) Ltd (Accelmed) is a private equity subsidiary of Arkin Moshe founded in 2009. The firm is headquartered in Miami, Florida. | Finance |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Finance |
Vuja De Sciences, Inc.
 Vuja De Sciences, Inc. Pharmaceuticals: MajorHealth Technology Vuja De Sciences, Inc. is engaged in biotechnology services. The company was founded by David Warshawsky, Rick Lampe, Robert E. Hurst and Raphael Nir and is headquartered in Hoboken, NJ. | Health Technology |
Mount Sinai Innovation Partners
Mount Sinai Innovation Partners Miscellaneous Commercial ServicesCommercial Services Mount Sinai Innovation Partners is a private company that focuses on translating discoveries and inventions into healthcare products and services that benefit patients and society. The company is based in New York, NY. The company is responsible for evaluating, patenting, marketing, and licensing new technologies, building research collaborations and partnerships with commercial and nonprofit entities, coaching innovators to advance commercially relevant translational discoveries, and fostering an ecosystem of entrepreneurship within the Mount Sinai research and health system communities. | Commercial Services |
| Medexplore Ventures | |
| Gromit Therapeutics |
